Inovio Pharmaceuticals, Inc. carries a market capitalization of 12.56M, placing it among publicly traded companies globally.
| Market Cap | 12.56M |
| Enterprise Value | N/A |
Inovio Pharmaceuticals, Inc.'s stock has declined approximately -96.35644% over the past 52 weeks. The 50-day moving average sits at 0.45, while the 200-day moving average is 0.47.
| Beta (5Y) | N/A |
| 52-Week Price Change | -96.35644% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.47 |
| Average Volume (20 Days) | N/A |
Inovio Pharmaceuticals, Inc.'s most recent stock split took place on June 6, 2014 with a 4:1 split ratio.
| Last Split Date | 6/6/2014 |
| Split Ratio | 4:1 |